甲状腺疾患治療市場

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Thyroid Gland Disorder Treatment Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Global Thyroid Gland Disorder Treatment Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Global Thyroid Gland Disorder Treatment Market - Breakup by Drug Type
6.1 Levothyroxine
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2025-2033)
6.2 Liothyronine
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2025-2033)
6.3 Propylthiouracil
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2019-2024)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2025-2033)
6.4 Imidazole-Based Compound
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2019-2024)
6.4.3 Market Segmentation
6.4.4 Market Forecast (2025-2033)
6.5 Others
6.5.1 Historical and Current Market Trends (2019-2024)
6.5.2 Market Forecast (2025-2033)
6.6 Attractive Investment Proposition by Drug Type

7 Global Thyroid Gland Disorder Treatment Market - Breakup by Diseases Type
7.1 Hyperthyroidism
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2025-2033)
7.2 Hypothyroidism
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2025-2033)
7.3 Attractive Investment Proposition by Diseases Type

8 Global Thyroid Gland Disorder Treatment Market - Breakup by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2025-2033)
8.2 Intravenous Route
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2025-2033)
8.3 Attractive Investment Proposition by Route of Administration

9 Global Thyroid Gland Disorder Treatment Market - Breakup by Distribution Channel
9.1 Wholesaler/Distributor
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2019-2024)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2025-2033)
9.2 Retailer
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2019-2024)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2025-2033)
9.3 Online
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2019-2024)
9.3.3 Market Segmentation
9.3.4 Market Forecast (2025-2033)
9.4 Others
9.4.1 Historical and Current Market Trends (2019-2024)
9.4.2 Market Forecast (2025-2033)
9.5 Attractive Investment Proposition by Distribution Channel

10 Global Thyroid Gland Disorder Treatment Market – Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Drivers
10.1.1.2 Historical and Current Market Trends (2019-2024)
10.1.1.3 Market Breakup by Drug Type
10.1.1.4 Market Breakup by Diseases Type
10.1.1.5 Market Breakup by Route of Administration
10.1.1.6 Market Breakup by Distribution Channel
10.1.1.7 Key Players
10.1.1.8 Market Forecast (2025-2033)
10.1.2 Canada
10.1.2.1 Market Drivers
10.1.2.2 Historical and Current Market Trends (2019-2024)
10.1.2.3 Market Breakup by Drug Type
10.1.2.4 Market Breakup by Diseases Type
10.1.2.5 Market Breakup by Route of Administration
10.1.2.6 Market Breakup by Distribution Channel
10.1.2.7 Key Players
10.1.2.8 Market Forecast (2025-2033)
10.2 Europe
10.2.1 Germany
10.2.1.1 Market Drivers
10.2.1.2 Historical and Current Market Trends (2019-2024)
10.2.1.3 Market Breakup by Drug Type
10.2.1.4 Market Breakup by Diseases Type
10.2.1.5 Market Breakup by Route of Administration
10.2.1.6 Market Breakup by Distribution Channel
10.2.1.7 Key Players
10.2.1.8 Market Forecast (2025-2033)
10.2.2 France
10.2.2.1 Market Drivers
10.2.2.2 Historical and Current Market Trends (2019-2024)
10.2.2.3 Market Breakup by Drug Type
10.2.2.4 Market Breakup by Diseases Type
10.2.2.5 Market Breakup by Route of Administration
10.2.2.6 Market Breakup by Distribution Channel
10.2.2.7 Key Players
10.2.2.8 Market Forecast (2025-2033)
10.2.3 United Kingdom
10.2.3.1 Market Drivers
10.2.3.2 Historical and Current Market Trends (2019-2024)
10.2.3.3 Market Breakup by Drug Type
10.2.3.4 Market Breakup by Diseases Type
10.2.3.5 Market Breakup by Route of Administration
10.2.3.6 Market Breakup by Distribution Channel
10.2.3.7 Key Players
10.2.3.8 Market Forecast (2025-2033)
10.2.4 Italy
10.2.4.1 Market Drivers
10.2.4.2 Historical and Current Market Trends (2019-2024)
10.2.4.3 Market Breakup by Drug Type
10.2.4.4 Market Breakup by Diseases Type
10.2.4.5 Market Breakup by Route of Administration
10.2.4.6 Market Breakup by Distribution Channel
10.2.4.7 Key Players
10.2.4.8 Market Forecast (2025-2033)
10.2.5 Spain
10.2.5.1 Market Drivers
10.2.5.2 Historical and Current Market Trends (2019-2024)
10.2.5.3 Market Breakup by Drug Type
10.2.5.4 Market Breakup by Diseases Type
10.2.5.5 Market Breakup by Route of Administration
10.2.5.6 Market Breakup by Distribution Channel
10.2.5.7 Key Players
10.2.5.8 Market Forecast (2025-2033)
10.2.6 Others
10.2.6.1 Historical and Current Market Trends (2019-2024)
10.2.6.2 Market Forecast (2025-2033)
10.3 Asia Pacific
10.3.1 China
10.3.1.1 Market Drivers
10.3.1.2 Historical and Current Market Trends (2019-2024)
10.3.1.3 Market Breakup by Drug Type
10.3.1.4 Market Breakup by Diseases Type
10.3.1.5 Market Breakup by Route of Administration
10.3.1.6 Market Breakup by Distribution Channel
10.3.1.7 Key Players
10.3.1.8 Market Forecast (2025-2033)
10.3.2 Japan
10.3.2.1 Market Drivers
10.3.2.2 Historical and Current Market Trends (2019-2024)
10.3.2.3 Market Breakup by Drug Type
10.3.2.4 Market Breakup by Diseases Type
10.3.2.5 Market Breakup by Route of Administration
10.3.2.6 Market Breakup by Distribution Channel
10.3.2.7 Key Players
10.3.2.8 Market Forecast (2025-2033)
10.3.3 India
10.3.3.1 Market Drivers
10.3.3.2 Historical and Current Market Trends (2019-2024)
10.3.3.3 Market Breakup by Drug Type
10.3.3.4 Market Breakup by Diseases Type
10.3.3.5 Market Breakup by Route of Administration
10.3.3.6 Market Breakup by Distribution Channel
10.3.3.7 Key Players
10.3.3.8 Market Forecast (2025-2033)
10.3.4 South Korea
10.3.4.1 Market Drivers
10.3.4.2 Historical and Current Market Trends (2019-2024)
10.3.4.3 Market Breakup by Drug Type
10.3.4.4 Market Breakup by Diseases Type
10.3.4.5 Market Breakup by Route of Administration
10.3.4.6 Market Breakup by Distribution Channel
10.3.4.7 Key Players
10.3.4.8 Market Forecast (2025-2033)
10.3.5 Australia
10.3.5.1 Market Drivers
10.3.5.2 Historical and Current Market Trends (2019-2024)
10.3.5.3 Market Breakup by Drug Type
10.3.5.4 Market Breakup by Diseases Type
10.3.5.5 Market Breakup by Route of Administration
10.3.5.6 Market Breakup by Distribution Channel
10.3.5.7 Key Players
10.3.5.8 Market Forecast (2025-2033)
10.3.6 Indonesia
10.3.6.1 Market Drivers
10.3.6.2 Historical and Current Market Trends (2019-2024)
10.3.6.3 Market Breakup by Drug Type
10.3.6.4 Market Breakup by Diseases Type
10.3.6.5 Market Breakup by Route of Administration
10.3.6.6 Market Breakup by Distribution Channel
10.3.6.7 Key Players
10.3.6.8 Market Forecast (2025-2033)
10.3.7 Others
10.3.7.1 Historical and Current Market Trends (2019-2024)
10.3.7.2 Market Forecast (2025-2033)
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Drivers
10.4.1.2 Historical and Current Market Trends (2019-2024)
10.4.1.3 Market Breakup by Drug Type
10.4.1.4 Market Breakup by Diseases Type
10.4.1.5 Market Breakup by Route of Administration
10.4.1.6 Market Breakup by Distribution Channel
10.4.1.7 Key Players
10.4.1.8 Market Forecast (2025-2033)
10.4.2 Mexico
10.4.2.1 Market Drivers
10.4.2.2 Historical and Current Market Trends (2019-2024)
10.4.2.3 Market Breakup by Drug Type
10.4.2.4 Market Breakup by Diseases Type
10.4.2.5 Market Breakup by Route of Administration
10.4.2.6 Market Breakup by Distribution Channel
10.4.2.7 Key Players
10.4.2.8 Market Forecast (2025-2033)
10.4.3 Others
10.4.3.1 Historical and Current Market Trends (2019-2024)
10.4.3.2 Market Forecast (2025-2033)
10.5 Middle East and Africa
10.5.1.1 Market Drivers
10.5.1.2 Historical and Current Market Trends (2019-2024)
10.5.1.3 Market Breakup by Drug Type
10.5.1.4 Market Breakup by Diseases Type
10.5.1.5 Market Breakup by Route of Administration
10.5.1.6 Market Breakup by Distribution Channel
10.5.1.7 Market Breakup by Country
10.5.1.8 Key Players
10.5.1.9 Market Forecast (2025-2033)
10.6 Attractive Investment Proposition by Region

11 Global Thyroid Gland Disorder Treatment Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Share by Key Players
11.4 Market Player Positioning
11.5 Top Winning Strategies
11.6 Competitive Dashboard
11.7 Company Evaluation Quadrant

12 Profiles of Key Players
12.1 Abbott Laboratories
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Business Strategies
12.1.4 Financials
12.1.5 SWOT Analysis
12.1.6 Major News and Events
12.2 Abbvie Inc.
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Business Strategies
12.2.4 Financials
12.2.5 SWOT Analysis
12.2.6 Major News and Events
12.3 Alvogen
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 GSK plc
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Business Strategies
12.4.4 Financials
12.4.5 SWOT Analysis
12.4.6 Major News and Events
12.5 IBSA Pharma Inc. (IBSA Group)
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
12.6 Lannett Company Inc.
12.6.1 Business Overview
12.6.2 Product Portfolio
12.6.3 Business Strategies
12.6.4 Financials
12.6.5 SWOT Analysis
12.6.6 Major News and Events
12.7 Merck KGaA
12.7.1 Business Overview
12.7.2 Product Portfolio
12.7.3 Business Strategies
12.7.4 Financials
12.7.5 SWOT Analysis
12.7.6 Major News and Events
12.8 Pfizer Inc.
12.8.1 Business Overview
12.8.2 Product Portfolio
12.8.3 Business Strategies
12.8.4 Financials
12.8.5 SWOT Analysis
12.8.6 Major News and Events
12.9 RLC Labs Inc.
12.9.1 Business Overview
12.9.2 Product Portfolio
12.9.3 Business Strategies
12.9.4 SWOT Analysis
12.9.5 Major News and Events
12.10 Viatris Inc.
12.10.1 Business Overview
12.10.2 Product Portfolio
12.10.3 Business Strategies
12.10.4 Financials
12.10.5 SWOT Analysis
12.10.6 Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

13 Global Thyroid Gland Disorder Treatment Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1    Overview
13.1.2    Drivers
13.1.3    Restraints
13.1.4    Opportunities
13.1.5    Impact Analysis
13.2 Porters Five Forces Analysis
13.2.1    Overview
13.2.2    Bargaining Power of Buyers
13.2.3    Bargaining Power of Suppliers
13.2.4    Degree of Competition
13.2.5    Threat of New Entrants
13.2.6    Threat of Substitutes
13.3 Value Chain Analysis

14 Strategic Recommendations

15 Appendix